Avatrombopag maleate, a novel thrombopoietin receptor agonist, has emerged as a promising therapeutic agent for the alleviation of various myeloid disorders. Its mechanism of action involves augmenting platelet https://deannajskk976932.blog-gold.com/40083840/avatrombopag-maleate-exploring-its-therapeutic-potential-in-myeloid-disorders